En enkelt dosis à 240 mg peroral aprepitant blev administreret til patienter med svær nyreinsufficiens (CrCl < 30 ml/ min) og til hæmodialysepatienter i det sene stadie (end stage) af nyresygdom (ESRD).
A single 240 mg dose of oral aprepitant was administered to patients with severe renal insufficiency (CrCl < 30 ml/ min) and to patients with end stage renal disease (ESRD) requiring haemodialysis.